Hosted on MSN1mon
A tiny anticancer weapon: Nano-sized particles trigger tumor cell self-destruction
The new approach, using engineered sEVs to target DR5, outperformed DR5-targeting antibodies ... vesicles to target DR5 because these nano-sized capsules—about a million times smaller than ...
Nature11mon
Therapeutic antibodies: past, present and future
Over the past 10 years, the market for monoclonal antibodies has grown exponentially. This focus issue brings together articles on the basic biology of antibodies and their therapeutic use ...
Nature1mon
Directing autophagy to degrade cell surface receptors
Using nano-AUTAB in combination with the primary antibodies Atz and Ctx enabled the simultaneous degradation of PDL1 and EGFR in MDA-MB-231 cells. Together, this study presents a potentially ...